tiprankstipranks
Trending News
More News >
Rezolute (RZLT)
NASDAQ:RZLT
US Market

Rezolute (RZLT) Stock Forecast & Price Target

Compare
746 Followers
See the Price Targets and Ratings of:

RZLT Analyst Ratings

Moderate Buy
9Ratings
Moderate Buy
5 Buy
4 Hold
0 Sell
Based on 9 analysts giving stock ratings to
Rezolute
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RZLT Stock 12 Month Forecast

Average Price Target

$6.57
▲(99.74% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Rezolute in the last 3 months. The average price target is $6.57 with a high forecast of $20.00 and a low forecast of $2.00. The average price target represents a 99.74% change from the last price of $3.29.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","6":"$6","11":"$11","16":"$16","21":"$21"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.571428571428572,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,6,11,16,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.24,4.52923076923077,5.818461538461539,7.107692307692307,8.396923076923077,9.686153846153847,10.975384615384616,12.264615384615384,13.553846153846154,14.843076923076923,16.13230769230769,17.42153846153846,18.71076923076923,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.24,3.4962637362637365,3.752527472527473,4.008791208791209,4.2650549450549455,4.521318681318681,4.777582417582417,5.033846153846154,5.290109890109891,5.546373626373627,5.802637362637363,6.058901098901099,6.315164835164835,{"y":6.571428571428572,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.24,3.144615384615385,3.0492307692307694,2.953846153846154,2.8584615384615386,2.763076923076923,2.667692307692308,2.5723076923076924,2.476923076923077,2.3815384615384616,2.286153846153846,2.190769230769231,2.0953846153846154,{"y":2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.25,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.43,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.92,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.96,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.225,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.42,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.87,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.17,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.43,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.32,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.17,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.36,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.24,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$20.00Average Price Target$6.57Lowest Price Target$2.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on RZLT
Craig-Hallum
Craig-Hallum
$2$4
Hold
21.58%
Upside
Reiterated
02/17/26
Craig-Hallum Remains a Hold on Rezolute (RZLT)
H.C. Wainwright Analyst forecast on RZLT
H.C. Wainwright
H.C. Wainwright
$5
Buy
51.98%
Upside
Reiterated
02/13/26
Valuation and Risks. Our Buy rating and $5 price target on Rezolute are based on 5.5x our 2036 discounted risk-adjusted revenue estimate of $99.2M. We adjust each pipeline asset for the probability of success (PoS): RZ358 for congenital hyperinsulinism (CHI) at 40%, given the strength of the RIZE data; 60% for Tumor HI, as the program is in the Phase 3 stage.
Wedbush Analyst forecast on RZLT
Wedbush
Wedbush
$1$2
Hold
-39.21%
Downside
Reiterated
02/13/26
Analysts Conflicted on These Healthcare Names: Rezolute (NASDAQ: RZLT), Dexcom (NASDAQ: DXCM) and Bruker (NASDAQ: BRKR)
BTIG
$5
Buy
51.98%
Upside
Reiterated
02/12/26
Rezolute: Positive Risk‑Reward Outlook Despite sunRIZE Miss, Backed by Encouraging Hyperinsulinism Data and Solid Cash Position
Maxim Group Analyst forecast on RZLT
Maxim Group
Maxim Group
$20$4
Buy
21.58%
Upside
Reiterated
12/12/25
Rezolute price target lowered to $4 from $20 at MaximRezolute price target lowered to $4 from $20 at Maxim
Guggenheim
$15$6
Buy
82.37%
Upside
Reiterated
12/11/25
Rezolute price target lowered to $6 from $15 at GuggenheimRezolute price target lowered to $6 from $15 at Guggenheim
Citizens JMP Analyst forecast on RZLT
Citizens JMP
Citizens JMP
Hold
Downgraded
12/11/25
Rezolute downgraded to Market Perform from Outperform at CitizensRezolute downgraded to Market Perform from Outperform at Citizens
Cantor Fitzgerald Analyst forecast on RZLT
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Downgraded
12/11/25
Rezolute downgraded to Neutral from Overweight at Cantor FitzgeraldRezolute downgraded to Neutral from Overweight at Cantor Fitzgerald
Jefferies
$15$20
Buy
507.90%
Upside
Reiterated
12/08/25
Rezolute price target raised to $20 from $15 at JefferiesRezolute price target raised to $20 from $15 at Jefferies
JonesTrading Analyst forecast on RZLT
JonesTrading
JonesTrading
$12
Buy
264.74%
Upside
Reiterated
05/15/25
Rezolute's Ersodetug Shows Promise in Phase 3 Trials for CHI, Reinforcing Buy Rating and $12 Price Target
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on RZLT
Craig-Hallum
Craig-Hallum
$2$4
Hold
21.58%
Upside
Reiterated
02/17/26
Craig-Hallum Remains a Hold on Rezolute (RZLT)
H.C. Wainwright Analyst forecast on RZLT
H.C. Wainwright
H.C. Wainwright
$5
Buy
51.98%
Upside
Reiterated
02/13/26
Valuation and Risks. Our Buy rating and $5 price target on Rezolute are based on 5.5x our 2036 discounted risk-adjusted revenue estimate of $99.2M. We adjust each pipeline asset for the probability of success (PoS): RZ358 for congenital hyperinsulinism (CHI) at 40%, given the strength of the RIZE data; 60% for Tumor HI, as the program is in the Phase 3 stage.
Wedbush Analyst forecast on RZLT
Wedbush
Wedbush
$1$2
Hold
-39.21%
Downside
Reiterated
02/13/26
Analysts Conflicted on These Healthcare Names: Rezolute (NASDAQ: RZLT), Dexcom (NASDAQ: DXCM) and Bruker (NASDAQ: BRKR)
BTIG
$5
Buy
51.98%
Upside
Reiterated
02/12/26
Rezolute: Positive Risk‑Reward Outlook Despite sunRIZE Miss, Backed by Encouraging Hyperinsulinism Data and Solid Cash Position
Maxim Group Analyst forecast on RZLT
Maxim Group
Maxim Group
$20$4
Buy
21.58%
Upside
Reiterated
12/12/25
Rezolute price target lowered to $4 from $20 at MaximRezolute price target lowered to $4 from $20 at Maxim
Guggenheim
$15$6
Buy
82.37%
Upside
Reiterated
12/11/25
Rezolute price target lowered to $6 from $15 at GuggenheimRezolute price target lowered to $6 from $15 at Guggenheim
Citizens JMP Analyst forecast on RZLT
Citizens JMP
Citizens JMP
Hold
Downgraded
12/11/25
Rezolute downgraded to Market Perform from Outperform at CitizensRezolute downgraded to Market Perform from Outperform at Citizens
Cantor Fitzgerald Analyst forecast on RZLT
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Downgraded
12/11/25
Rezolute downgraded to Neutral from Overweight at Cantor FitzgeraldRezolute downgraded to Neutral from Overweight at Cantor Fitzgerald
Jefferies
$15$20
Buy
507.90%
Upside
Reiterated
12/08/25
Rezolute price target raised to $20 from $15 at JefferiesRezolute price target raised to $20 from $15 at Jefferies
JonesTrading Analyst forecast on RZLT
JonesTrading
JonesTrading
$12
Buy
264.74%
Upside
Reiterated
05/15/25
Rezolute's Ersodetug Shows Promise in Phase 3 Trials for CHI, Reinforcing Buy Rating and $12 Price Target
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Rezolute

3 Months
xxx
Success Rate
6/10 ratings generated profit
60%
Average Return
+21.87%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +21.87% per trade.
1 Year
Douglas TsaoH.C. Wainwright
Success Rate
13/19 ratings generated profit
68%
Average Return
+80.16%
a rating ―
Copying Douglas Tsao's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +80.16% per trade.
2 Years
xxx
Success Rate
11/19 ratings generated profit
58%
Average Return
+88.17%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 57.89% of your transactions generating a profit, with an average return of +88.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RZLT Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
8
12
11
13
9
Buy
8
12
8
4
2
Hold
0
0
4
5
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
24
23
22
18
In the current month, RZLT has received 11 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. RZLT average Analyst price target in the past 3 months is 6.57.
Each month's total comprises the sum of three months' worth of ratings.

RZLT Financial Forecast

RZLT Earnings Forecast

The previous quarter’s earnings for RZLT were -$0.22.
The previous quarter’s earnings for RZLT were -$0.22.
No data currently available

RZLT Sales Forecast

The previous quarter’s earnings for RZLT were $0.00.
The previous quarter’s earnings for RZLT were $0.00.

RZLT Stock Forecast FAQ

What is RZLT’s average 12-month price target, according to analysts?
Based on analyst ratings, Rezolute’s 12-month average price target is 6.57.
    What is RZLT’s upside potential, based on the analysts’ average price target?
    Rezolute has 99.74% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is RZLT a Buy, Sell or Hold?
          Rezolute has a consensus rating of Moderate Buy which is based on 5 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Rezolute’s price target?
            The average price target for Rezolute is 6.57. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $20.00 ,the lowest forecast is $2.00. The average price target represents 99.74% Increase from the current price of $3.29.
              What do analysts say about Rezolute?
              Rezolute’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of RZLT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.